SRXN1 and hypertrophic cardiomyopathy: Using STFs, we then show that many pathophysiological insults of hypertrophic cardiomyopathy (HCM) such as R403Q myosin mutation, hyper-phosphorylation of myosin light chains, and increased ADP:ATP ratio destabilize the myosin SRX population.